Table 1.
No MRI (N, %) | MRI (N, %) | |||
---|---|---|---|---|
Overall | Overall | |||
Total N = 19,324 | 13,869 (72.0 %) | 5,455 (28.0%) | ||
Age At Exam (years) | ||||
<50 | 2529 | 18.2 | 1521 | 27.9 |
50–59 | 3401 | 24.5 | 1599 | 29.3 |
60–69 | 3930 | 28.3 | 1472 | 27.0 |
70–79 | 2771 | 20.0 | 714 | 13.1 |
80–89 | 1238 | 8.9 | 149 | 2.7 |
Race (NCI Reporting Standard) | ||||
White, non Hispanic | 10366 | 76.1 | 4057 | 75.5 |
Black, non Hispanic | 1382 | 10.1 | 594 | 11.1 |
Asian | 1260 | 9.2 | 404 | 7.5 |
Non-Hispanic Pacific Islander, Alaska Native, American Indian |
68 | 0.5 | 27 | 0.5 |
Hispanic | 550 | 4.0 | 292 | 5.4 |
Other, Mixed, Unknown | 243 | 1.8 | 81 | 1.5 |
First Degree Family History of Breast Cancer | ||||
No | 9974 | 76.5 | 3890 | 75.8 |
Yes | 3062 | 23.5 | 1242 | 24.2 |
Unknown | 833 | 6.0 | 323 | 5.9 |
Previous biopsy/aspiration | ||||
None | 8463 | 65.9 | 2925 | 61.9 |
Biopsy Only | 2856 | 22.2 | 1320 | 27.9 |
Aspiration Only | 615 | 4.8 | 224 | 4.7 |
Biopsy and Aspiration | 904 | 7.0 | 259 | 5.5 |
Unknown | 1031 | 7.4 | 727 | 13.3 |
Menopause | ||||
Pre | 2847 | 23.1 | 1660 | 35.3 |
Post | 9460 | 76.9 | 3047 | 64.7 |
Unknown | 1562 | 11.3 | 748 | 13.7 |
Current hormone therapy use | ||||
No | 9146 | 95.4 | 3566 | 96.2 |
Yes | 436 | 4.6 | 141 | 3.8 |
Unknown | 4287 | 30.9 | 1748 | 32.0 |
Laterality of index biopsy2 | ||||
Left | 6770 | 48.8 | 2683 | 49.2 |
Right | 6936 | 50.0 | 2724 | 49.9 |
Bilateral | 163 | 1.2 | 48 | 0.9 |
Index biopsy2 year | ||||
2005–2008 | 4532 | 32.7 | 591 | 10.8 |
2009–2011 | 3395 | 24.5 | 1425 | 26.1 |
2012–2014 | 3447 | 24.9 | 1812 | 33.2 |
2015–2017 | 2495 | 18.0 | 1627 | 29.8 |
Geo coding education | ||||
<=Q1 | 3324 | 26.1 | 1288 | 25.8 |
Q1 – Q2 | 3515 | 27.6 | 1228 | 24.6 |
Q2 – Q3 | 3296 | 25.9 | 1393 | 27.9 |
> Q3 | 2593 | 20.4 | 1075 | 21.6 |
Unknown | 1141 | 8.2 | 471 | 8.6 |
Index biopsy2 | ||||
DCIS | 3103 | 22.4 | 1049 | 19.2 |
Invasive3 | 10766 | 77.6 | 4406 | 80.8 |
Mode of Detection4 | ||||
Screen Detected | 8754 | 64.3 | 3178 | 59.1 |
Interval Detected | 2759 | 20.3 | 1303 | 24.3 |
Clinically Detected | 2102 | 15.4 | 892 | 16.6 |
Unknown Mode | 254 | 1.8 | 82 | 1.5 |
Breast Density | ||||
Almost entirely fat | 1442 | 10.4 | 284 | 5.2 |
Scattered fibroglandular | 5996 | 43.2 | 1745 | 32.0 |
Heterogeneously dense | 5347 | 38.6 | 2622 | 48.1 |
Extremely dense | 1084 | 7.8 | 804 | 14.7 |
Histology Type | ||||
DCIS | 3103 | 28.8 | 1049 | 23.5 |
Invasive, Ductal | 6741 | 62.5 | 2813 | 63.1 |
Invasive, Lobular | 733 | 6.8 | 521 | 11.7 |
Invasive, Ductal & Lobular | 210 | 1.9 | 73 | 1.6 |
Unknown | 3082 | 22.2 | 999 | 18.3 |
Surgery Type | ||||
Lumpectomy | 9787 | 70.6 | 3250 | 59.6 |
Mastectomy | 4082 | 29.4 | 2205 | 40.4 |
All | 13869 | 5455 |
Preoperative MRI was defined as any MRI completed between index biopsy and the definitive surgery
Index biopsy was defined as the biopsy associated with the pathologically-determined breast cancer diagnosis of invasive breast cancer or ductal carcinoma in situ.
Invasive cancer includes lobular invasive, ductal invasive, and other invasive.
Mode of detection is as follows: Screen detected: cancer detected within 12 months of a positive screening mammogram; Interval detected: cancer detected cancer within 27 months of a prior negative screening exam; Clinically detected: Cancer detected on a diagnostic exam with no mammogram in prior 27 months.